Mayer Arie
SEC CIK 1796583 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | Dir | 168.0K | $19.5K | $76.8K | 9 | 2021-11-01 | 2025-12-31 |
Most active insiders at ORMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hexter Joshua | COO, CBO | — | $611.4K |
| 2 | Gabay Avraham | CFO | — | $330.7K |
| 3 | Reznick Yehuda | Dir | — | — |
| 4 | Aghion Daniel | Dir | — | — |
| 5 | Shapiro Benjamin | Dir | — | — |
| 6 | Mayer Arie | Dir | — | — |
| 7 | Kidron Miriam | CSO, Dir | — | — |
| 8 | KIDRON NADAV | Pres, CEO, Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-05 | 2025-12-31 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | A - Grant | — | +34.9K | 168.0K | +26% | — |
| M | 2025-06-09 | 2025-06-05 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | A - Grant | — | +37.0K | 133.1K | +38% | — |
| M | 2024-01-08 | 2024-01-04 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | A - Grant | — | +39.3K | 86.8K | +83% | — |
| 2023-04-20 | 2023-04-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | A - Grant | — | +30.0K | 56.8K | +112% | — | |
| M | 2023-04-04 | 2023-04-03+ | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | P - Purchase | $2.22 | +8,809 | 23.0K | +62% | +$19.5K |
| 2022-08-01 | 2022-07-28 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | A - Grant | — | +12.0K | 18.0K | +200% | — | |
| 2022-05-10 | 2021-11-01 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | S - Sale | $25.60 | -3,000 | 0 | -100% | -$76.8K | |
| A | 2022-05-10 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | A - Grant | — | +6,000 | 6,000 | New | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | Mayer Arie | Dir | A - Grant | — | +6,000 | 9,000 | +200% | — |
Purchase Sale Sale after option exercise All abbreviations